Search - tctmd.com

Displaying 121 - 140 of 214

Sort: Relevancy | Date

Presentation TCT 2013

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

Presenter: Masato Nakamura

October 29, 2013

News Industry News

MiStent SES Shown to be Unique in Clinical Setting

October 29, 2013

Presentation TCT 2013

The Evolution from Endeavor to Resolute: Stent Design Considerations and Results

Presenter: David Kandzari

October 28, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

在使用DES接受PCI治疗的患者中，西洛他唑与双倍剂量氯吡格雷一样安全

Yael L. Maxwell

September 20, 2013

News Daily News

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Yael L. Maxwell

September 20, 2013

News Daily News

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Yael L. Maxwell

September 20, 2013

News Daily News

ISAR-LEFT MAIN 2试验：第二代DES治疗冠状动脉左主干疾病疗效相近

Yael L. Maxwell

September 13, 2013

News Daily News

ISAR-LEFT MAIN 2 Published: Second-Generation DES Comparable in Left Main CAD

Yael L. Maxwell

September 13, 2013

News Daily News

ISAR-LEFT MAIN 2 Publicado: Los SLF de 2ª Generación son Comparables en la EAC de Tronco Principal Izdo

Yael L. Maxwell

September 13, 2013

News Conference News ESC 2013

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

Yael L. Maxwell

September 02, 2013

News Daily News

SES Show Advantage Over ZES, PES for Diabetic Patients

Yael L. Maxwell

June 20, 2013

News Daily News

Los SLS Sacan Ventaja a los SLZ y SLP en Pacientes Diabéticos

Yael L. Maxwell

June 20, 2013

News Industry News

Micell Technologies Receives CE Mark Approval for MiStent SES

June 12, 2013

News Daily News

Meta-analysis: Cobalt-Chromium EES Take the Lead Over BMS, Other DES in STEMI

L.A. McKeown

June 07, 2013

News Daily News

Prometedora Nueva Técnica de Colocación de Stents para ‘Verdaderas’ Lesiones en las Bifurcaciones Coronarias

Yael L. Maxwell

May 24, 2013

News Daily News

Novel Stenting Technique Shows Promise for ‘True’ Bifurcation Lesions

Yael L. Maxwell

May 24, 2013

News Daily News

TWENTE: Still Few Differences between ZES and EES at 2 Years

L.A. McKeown

May 03, 2013

News Daily News

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

L.A. McKeown

May 03, 2013

News Industry News

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

May 01, 2013

Advertisement

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

MiStent SES Shown to be Unique in Clinical Setting

The Evolution from Endeavor to Resolute: Stent Design Considerations and Results

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

在使用DES接受PCI治疗的患者中，西洛他唑与双倍剂量氯吡格雷一样安全

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

ISAR-LEFT MAIN 2试验：第二代DES治疗冠状动脉左主干疾病疗效相近

ISAR-LEFT MAIN 2 Published: Second-Generation DES Comparable in Left Main CAD

ISAR-LEFT MAIN 2 Publicado: Los SLF de 2ª Generación son Comparables en la EAC de Tronco Principal Izdo

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

SES Show Advantage Over ZES, PES for Diabetic Patients

Los SLS Sacan Ventaja a los SLZ y SLP en Pacientes Diabéticos

Micell Technologies Receives CE Mark Approval for MiStent SES

Meta-analysis: Cobalt-Chromium EES Take the Lead Over BMS, Other DES in STEMI

Prometedora Nueva Técnica de Colocación de Stents para ‘Verdaderas’ Lesiones en las Bifurcaciones Coronarias

Novel Stenting Technique Shows Promise for ‘True’ Bifurcation Lesions

TWENTE: Still Few Differences between ZES and EES at 2 Years

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content